Leaflet CINKONA 300mg / 2ml solution for injection


Indicated for: malaria

Route of administration: injectable

Substance: quinine hydrochloride (antimalarial)

ATC: P01BC01 (Antiparasitic products, insecticides and repellents | Antimalarials | Methanolquinolines)

Quinine hydrochloride is a medication primarily used for the treatment of severe malaria caused by Plasmodium falciparum. It works by interfering with the parasite's metabolism, destroying it within the host cells.

The medication is administered orally or intravenously, as directed by a doctor, depending on the severity of the infection. It is important for patients to follow the treatment regimen and inform the doctor about any other medications being used.

Patients should be aware of potential side effects, such as nausea, vomiting, dizziness, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, vomiting, and dizziness. In rare cases, severe reactions such as cardiac arrhythmias or allergic reactions may occur. Patients should be informed of these risks before use.

General data about CINKONA 300mg / 2ml

  • Substance: quinine hydrochloride
  • Date of last drug list: 01-06-2016
  • Commercial code: W59942001
  • Concentration: 300mg / 2ml
  • Pharmaceutical form: solution for injection
  • Quantity: 5
  • Product type: generic
  • Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.